Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016–2018): an observational, prospective cohort study

Fig. 2

Proportion of urine and serum samples that tested positive for dengue and Zika viral RNA at baseline (day 0–7 of symptom onset), and follow-up visits at day 3 (days 8–10 of symptoms onset) and 7 (days 7–14 of symptoms onset) after enrollment in (cohort Zik01. Mexico, 2016–2018). Description: Bars figure showing the proportion of patients that tested positive for Zika and dengue at visits on day 0, 3 and 7 after enrollment in the cohort. All samples were tested for dengue and Zika viral RNA at days 14, 28 and 180 days after enrollment but none tested positive. There were no patients with dual infection

Back to article page